tiprankstipranks
Trending News
More News >
Perspective Therapeutics (CATX)
:CATX
US Market

Perspective Therapeutics (CATX) Income Statement

Compare
1,382 Followers

Perspective Therapeutics Income Statement

Last quarter (Q4 2024), Perspective Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Perspective Therapeutics's net income was $-40.17M. See Perspective Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Jun 22Jun 21
Total Revenue
$ 0.00$ 1.43M$ 7.10M$ 10.79M$ 10.05M
Gross Profit
$ 0.00$ 1.43M$ 1.63M$ 4.62M$ 5.12M
Operating Expenses
$ 92.34M$ 42.38M$ 17.43M$ 12.01M$ 8.56M
Depreciation and Amortization
$ 0.00$ 981.00K$ 344.00K$ 248.00K$ 9.00K
EBITDA
$ 10.46M$ -39.96M$ -14.84M$ -7.39M$ -3.43M
Operating Income
$ 10.46M$ -40.94M$ -15.18M$ -7.39M$ -3.44M
Other Income/Expenses
$ -91.83M$ 835.00K$ 512.00K$ 119.00K$ 50.00K
Pretax Income
$ -81.38M$ -40.11M$ -14.67M$ -7.27M$ -3.39M
Net Income
$ -79.28M$ -46.51M$ -14.67M$ -7.15M$ -3.19M
Per Share Metrics
Basic EPS
$ -1.23$ -1.40$ -0.27$ -0.13$ -0.06
Diluted EPS
$ -1.23$ -1.40$ -0.27$ -0.13$ -0.06
Weighted Average Shares Outstanding
64.42M 26.76M 54.91M 54.91M 54.91M
Weighted Average Shares Outstanding (Diluted)
64.42M 26.76M 54.91M 54.91M 54.91M
Currency in USD

Perspective Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis